He has BE in chemical engineering from the University College Dublin and a PhD in biomedical engineering from Johns Hopkins University. Dr. MagGabhann’s research involves creating computational models of physical processes to predict therapies, particularly around inhibiting vascular endothelia growth factor signaling in cancer. His work has appeared in journals such as PloS, Computational Biology and American Journal of Physiology Heart and Circulatory Physiology.